News: CMS releases new codes for COVID-19 immunization status
November 25, 2021
CDI Strategies - Volume 15, Issue 52
CMS released seven new procedure codes related to the introduction or infusion of therapeutics, including vaccines for COVID-19 treatments, effective April 1, 2022. The seven new procedure codes include:
- XW013V7 – Introduction of COVID-19 vaccine does 3 into subcutaneous tissue, percutaneous approach, new technology group 7
- XW013W7 – Introduction of COVID-19 vaccine booster into subcutaneous tissue, percutaneous approach, new technology group 7
- XW023V7 – Introduction of COVID-19 vaccine dose 3 into muscle, percutaneous approach, new technology group 7
- XW023W7 – Introduction of COVID-19 vaccine booster into muscle, percutaneous approach, new technology group 7
- XW0DXR7 – Introduction of fostamatinib into mouth and pharynx, external approach, new technology group 7
- XW0G7R7 – Introduction of fostamatinib into upper GI, via natural or artificial opening, new technology group 7
- XW0H7R7 – Introduction of fostamatinib into lower GI, via natural or artificial opening, new technology group 7
Additionally, three new diagnosis codes are being implemented into ICD-10-CM for reporting COVID-19 vaccination status, again effective April 1, 2022. Those three new codes are:
- Z28.310 – Unvaccinated for COVID-19
- Z28.311 – Partially vaccinated for COVID-19
- Z28.39 – Other under immunization status
The full updates for released ICD-10 MS-DRGs effective April 1,2022, can be found on the CMS website.